• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Lifshitz Law PLLC Announces Investigations of HCCI, PRDS, NLTX, CCF

    7/22/23 8:07:00 PM ET
    $CCF
    $HCCI
    $NLTX
    $PRDS
    Building Products
    Consumer Discretionary
    Miscellaneous
    Industrials
    Get the next $CCF alert in real time by email

    NEW YORK, July 22, 2023 (GLOBE NEWSWIRE) --

    Heritage-Crystal Clean, Inc. (NASDAQ:HCCI)

    Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of HCCI to an investment affiliate of J.F. Lehman & Company for $45.50 per share in cash for each share of HCCI common stock owned.

    If you are a HCCI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

    Pardes Biosciences, Inc. (NASDAQ:PRDS)

    Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of PRDS to MediPacific, Inc. for a price per share of not less than $2.02 in cash, an additional cash amount of not more than $0.17 per share at closing, and one non-tradeable contingent value right for each share of PRDS common stock owned.

    If you are a PRDS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

    Neoleukin Therapeutics, Inc. (NASDAQ:NLTX)

    Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of NLTX and Neurogene Inc. Under the terms of the proposed merger, NLTX will issue to pre-merger Neurogene Inc. stockholders shares of NLTX common stock as merger consideration in exchange for the cancellation of shares of capital stock of Neurogene Inc. and NLTX stockholders will be issued non-tradeable contingent value rights. Following the merger, pre-merger NLTX stockholders are expected to own approximately 16% of the combined company.

    If you are a NLTX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

    Chase Corporation (NYSE:CCF)

    Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of CCF to an affiliate of investment funds managed by KKR for $127.50 per share in cash for each share of CCF common stock owned.

    If you are a CCF investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

    ATTORNEY ADVERTISING.© 2023 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

    Contact:

    Joshua M. Lifshitz, Esq.

    Lifshitz Law PLLC

    Phone: 516-493-9780

    Facsimile: 516-280-7376

    Email: [email protected]



    Get the next $CCF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CCF
    $HCCI
    $NLTX
    $PRDS

    CompanyDatePrice TargetRatingAnalyst
    Pardes Biosciences Inc.
    $PRDS
    7/18/2023Mkt Outperform → Mkt Perform
    JMP Securities
    Heritage-Crystal Clean Inc.
    $HCCI
    4/18/2023$42.00Buy
    Truist
    Heritage-Crystal Clean Inc.
    $HCCI
    1/11/2023$40.00Buy
    DA Davidson
    Pardes Biosciences Inc.
    $PRDS
    3/15/2022Outperform
    SVB Leerink
    Neoleukin Therapeutics Inc.
    $NLTX
    3/2/2022$30.00 → $25.00Overweight
    Piper Sandler
    Pardes Biosciences Inc.
    $PRDS
    1/18/2022$25.00Buy
    Jefferies
    Heritage-Crystal Clean Inc.
    $HCCI
    10/22/2021$34.00 → $39.00Buy
    Needham
    Neoleukin Therapeutics Inc.
    $NLTX
    8/6/2021$30.00Overweight
    Piper Sandler
    More analyst ratings